Đorđe Miljković

10PUBLICATIONS
25CO-AUTHORS
Molecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 04, 2026
FFAR2 activation induces IL-22-dependent intestinal immune responses to suppress CNS autoimmunity.

|Mar 12, 2026
Changes in Adaptive Immunity in Autoimmune Diseases and Aging: Shared Features, Key Differences, and Implications for Immune Vulnerability.

Bojan Jevtić, Milica Lazarević, Đorđe Miljković

|Dec 11, 2025
Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor.

Bojan Jevtić, Nikola Momcilovic, Goran Stegnjaić

|Jun 25, 2025
Multiple low dose streptozotocin-induced diabetes as a model for studying autoimmune diabetes in humans.

Ivan Koprivica, Suzana Stanisavljević, Dragica Mićanović

|Nov 14, 2024
Immunomodulatory effects of HYCO-3, a dual action CO-releaser/Nrf2 activator.

Goran Stegnjaić, Neda Nikolovski, Suzana Stanisavljević

|Jul 13, 2024
Anti-Neuroinflammatory Effects of a Novel Bile Acid Derivative.

Srđan Bjedov, Goran Stegnjaić, Suzana Stanisavljević

Pageof 2

Frequent Collaborators

4 joint publications

Suzana Stanisavljević

3 joint publications

Mirjana Dimitrijević

2 joint publications

Dragica Mićanović

2 joint publications

Neda Nikolovski